These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8271390)

  • 21. [New therapeutic possibilities in AIDS].
    Heinzl S
    Med Monatsschr Pharm; 1996 May; 19(5):121. PubMed ID: 8684307
    [No Abstract]   [Full Text] [Related]  

  • 22. The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity.
    Rayne F; Vendeville A; Bonhoure A; Beaumelle B
    J Virol; 2004 Nov; 78(21):12054-7. PubMed ID: 15479845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent status of HIV-1 gene expression inhibitors.
    Baba M
    Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting a deadly scrap of genetic code.
    Cowley G
    Newsweek; 1996 Dec; 128(23):68-9. PubMed ID: 10162944
    [No Abstract]   [Full Text] [Related]  

  • 26. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters.
    Rezza G; Fiorelli V; Dorrucci M; Ciccozzi M; Tripiciano A; Scoglio A; Collacchi B; Ruiz-Alvarez M; Giannetto C; Caputo A; Tomasoni L; Castelli F; Sciandra M; Sinicco A; Ensoli F; Buttò S; Ensoli B
    J Infect Dis; 2005 Apr; 191(8):1321-4. PubMed ID: 15776379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
    Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
    Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV protease as an inhibitor target for the treatment of AIDS.
    Darke PL; Huff JR
    Adv Pharmacol; 1994; 25():399-454. PubMed ID: 8204507
    [No Abstract]   [Full Text] [Related]  

  • 29. [HIV protease inhibitors (new possibilities in the treatment of HIV infection and AIDS)].
    Bálint GS
    Orv Hetil; 1998 Jun; 139(24):1471-4. PubMed ID: 9658865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saquinavir thwarts resistance.
    AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor.
    Montembault M; Vo-Thanh G; Deyine A; Fargeas V; Villiéras M; Adjou A; Dubreuil D; Esquieu D; Grégoire C; Opi S; Péloponèse JM; Campbell G; Watkins J; de Mareuil J; Aubertin AM; Bailly C; Loret E; Lebreton J
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1543-6. PubMed ID: 15006399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of HIV-based retrovirus vector].
    Hayashi T; Okamoto T
    Nihon Rinsho; 1993 Sep; 51 Suppl():615-20. PubMed ID: 8271447
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association.
    Zeng L; Li J; Muller M; Yan S; Mujtaba S; Pan C; Wang Z; Zhou MM
    J Am Chem Soc; 2005 Mar; 127(8):2376-7. PubMed ID: 15724976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tat and anti-HIV activities of trimers of n-alkylglycines.
    Márquez N; Sancho R; Macho A; Moure A; Masip I; Messeguer A; Muñoz E
    Biochem Pharmacol; 2006 Feb; 71(5):596-604. PubMed ID: 16405868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular basis of anti-retroviral therapy.
    Weber J
    J Antimicrob Chemother; 1993 Dec; 32(6):789-92. PubMed ID: 7511578
    [No Abstract]   [Full Text] [Related]  

  • 37. Shooting at a new HIV target.
    Palca J
    Science; 1990 Jan; 247(4941):410. PubMed ID: 2405485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-HIV compounds].
    Kiso Y; Kisanuki S
    Nihon Rinsho; 1993 Sep; 51 Suppl():235-40. PubMed ID: 8271390
    [No Abstract]   [Full Text] [Related]  

  • 39. Turnabout on AIDS drug.
    Science; 1992 Jan; 255(5041):154. PubMed ID: 1553539
    [No Abstract]   [Full Text] [Related]  

  • 40. New AIDS drug poised to move into development.
    Science; 1991 Dec; 254(5039):1715. PubMed ID: 1763318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.